Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-associated pharmacodynamic changes.

P P Lamy

    Methods and Findings in Experimental and Clinical Pharmacology
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Pharmacodynamic changes in aging adults, alongside pharmacokinetic shifts and polypharmacy, alter drug effectiveness and increase adverse drug reactions. Recognizing these age-related drug action changes is crucial for preventing severe clinical outcomes, especially with cardiac and central nervous system medications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diabetic patient compliance as a function of counseling. 1979.

    The Annals of pharmacotherapy·2006
    Same author

    Avoiding polypharmacy and iatrogenesis in the nursing home.

    Maryland medical journal (Baltimore, Md. : 1985)·1994
    Same author

    Understanding and managing Alzheimer's disease.

    The Journal of practical nursing·1993
    Same author

    Institutionalisation and drug use in older adults in the US.

    Drugs & aging·1993
    Same author

    Drug prescribing for the elderly.

    Archives of family medicine·1993
    Same author

    Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

    Drugs & aging·1991
    Same journal

    [Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Treatment algorithm for gastrointestinal graft-versus-host disease].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Classification of chronic graft-versus-host disease].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Pegfilgrastim in hematopoietic stem cell transplantation].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

    Methods and findings in experimental and clinical pharmacology·2011
    See all related articles

    Area of Science:

    • Gerontology
    • Pharmacology
    • Clinical Medicine

    Background:

    • Aging is associated with numerous physiological changes that can affect drug response.
    • Polypharmacy (multiple drug use) is common in the elderly and complicates drug management.
    • Age-related alterations in drug action can lead to significant adverse events.

    Purpose of the Study:

    • To highlight the impact of age-related pharmacodynamic changes on drug action in the elderly.
    • To emphasize the role of these changes, combined with pharmacokinetic alterations and polypharmacy, in adverse drug reactions.
    • To underscore the clinical significance of recognizing these changes, particularly for drugs affecting the heart and central nervous system.

    Main Methods:

    • Review of identified pharmacodynamic changes with aging.

    Related Experiment Videos

  • Consideration of age-associated pharmacokinetic alterations.
  • Analysis of the impact of multiple drug use in the elderly.

    • Main Results:

    • Pharmacodynamic alterations are identified as a key factor in altered drug action in the elderly.
    • Age-related pharmacokinetic changes and polypharmacy likely contribute to altered drug responses.
    • These combined factors increase the incidence of adverse drug reactions with advancing age.

    Conclusions:

    • Age-related pharmacodynamic changes significantly influence drug efficacy and safety in older adults.
    • Failure to recognize these age-associated drug action modifications can result in major adverse clinical outcomes.
    • Particular attention is needed for medications impacting the cardiovascular and central nervous systems in geriatric populations.